首页 | 本学科首页   官方微博 | 高级检索  
     

胃力康颗粒与H2受体拮抗剂联合抗生素治疗消化性溃疡临床观察
引用本文:郭公新,艾迎春. 胃力康颗粒与H2受体拮抗剂联合抗生素治疗消化性溃疡临床观察[J]. 黑龙江医药科学, 2002, 25(6): 22-23
作者姓名:郭公新  艾迎春
作者单位:佳木斯大学第一附属医院消化内科
摘    要:目的研究胃力康颗粒用于治疗消化性溃疡的疗效及安全性.方法将经胃镜证实的消化性溃疡患者随机分成治疗组36例和对照组38例,治疗组应用胃力康颗粒10g,1日3次口服,连服4周;西米替丁0.2g,1日3次口服,0.4g每晚睡前口服,连服4周;阿莫西林0.5g,1日3次口服,连服2周.对照组应用硫糖铝1.0g,1日3次口服,连服4周,西米替丁及阿莫西林同治疗组.治疗前后分别做胃镜检查,治疗期间每周随访一次,并记录症状改善情况及不良反应.结果治疗组溃疡愈合率和总有效率分别为94.4%和97.2%,而对照组分别为94.8%和97.4%,两组比较差异无显著性(P>0.05)各项症状改善情况两组相仿(P>0.05).治疗期间两组均有良好的耐受性.结论胃力康颗粒对消化溃疡疗效确切,是一种良好的抗溃疡药物.

关 键 词:胃力康颗粒 中西医结合 H2受体拮抗剂 抗生素 消化性溃疡 临床观察
文章编号:1008-0104(2002)06-0022-01
修稿时间:2002-07-16

Weilikang and H2-receptor blocker in combination with antibiotic in the treatment of active peptic ulcer
GUO Gongxin AI Yingchun. Weilikang and H2-receptor blocker in combination with antibiotic in the treatment of active peptic ulcer[J]. Heilongjiang Medicine and Pharmacy, 2002, 25(6): 22-23
Authors:GUO Gongxin AI Yingchun
Abstract:Objective: To study the efficacy and safety of weilikang in treatment of active peptic ulcer. Methods: 74 patients with active peptic ulcer were at random divided into two groups: experimental group(36) and control group(38). Experimental group received weilikang Cimetidinum and Armocilin, and control group recieved liutanglu and others. Both took for 4 weaks. Results: After 4 weeks?treatment, healing rate. and effective rate of experimental group were 94.4% and 97.2%, and those of control group were 94.8% and 97.4%(P>0.05). Conclusions: In the study, weilikang producea healing rate equivalent to control group in active peptic ulcer and achieved the same symptoms relieving rate.Weilikang was well tolerated.
Keywords:duodental ulcer  gastric ulcer  weilikang
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号